Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors’ opinions or evaluations. The rate on a 30-year fixed refinance rose to 6.78% today, according to the Mortgage Research Center. The average rate on a 15-year mortgage refinance is 5.64%. On a 20-year mortgage refinance, the average … Read more
In celebration of Women’s History Month, Brown, Goldstein & Levy celebrates the vital role of women throughout history. We are proud of BGL’s managing partner, Jessie Weber, and all our women attorneys who go above and beyond to bring the highest quality legal services to clients in Maryland, DC, and across the country. From our … Read more
By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Advancing EB06 for Treating Vitiligo Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease that causes areas of the skin to lose color, … Read more
Communities across Pennsylvania can now apply for state grants to fund parks, recreation, and conservation projects, as the Department of Conservation and Natural Resources (DCNR) opens its latest round of Community Conservation Partnerships Program (C2P2) funding. Applications are open now through April 2 at 4:00 PM. These grants are a key part of the Shapiro Administration’s commitment to revitalizing communities … Read more
By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Planning Phase 3 Oral Insulin study under revised protocol, new CRO agreement in place Oramed Pharmaceuticals (NASDAQ:ORMP) has pivoted its clinical R&D focus to prioritize studying ORMD 0801 for subpopulations of patients with pooled specific parameters who responded well to oral insulin in its prior … Read more
